Deadline: 15-Sep-21
The European Commission (EC) is offering Action Grants for a Project on Quality and Safety of Radiation Technology in Diagnosis and Treatment of Cancer to enhance the quality and safety and optimise radiation technology in medicine.
Activities
This action will be implemented in close cooperation with the Strategic Agenda for Medical Ionising Radiation Applications of nuclear and radiation technology and the activities will be grouped as follows:
- Quality and safety of medical radiation applications: The action will include accompanying activities to:
- build co-operations, support and monitor medical radiations applications,
- develop evidence-based guidance and practical tools for quality and safety of medical ionising radiation applications,
- build EU dose registry for patients undergoing radiological and nuclear medicine imaging, and
- support to align Euratom / EU action on medical radiological diagnostic and therapeutic equipment, including acceptance and performance testing, technical standards and harmonised reporting of adverse events, align Euratom / EU action on radiopharmaceuticals, and support actions for clinical audit of radiology, nuclear medicine and radiotherapy practices.
- Workforce education and training: The action will include activities for the:
- Union-wide monitoring of workforce availability, education and training;
- capacity building in modern radionuclide cancer diagnosis, therapy and ‘theragnostics’; and
- development of EU curricula and certification schemes in the quality and safety of radiology, nuclear medicine and radiotherapy.
- Equal access to modern medical radiation technology and interventions: The action will include:
- monitoring of the Union imaging and radiotherapy equipment base and the availability of modern quality and safety features;
- develop quality and safety criteria and optimised imaging protocols for advanced medical imaging;
- cover medical radiation technology, including diagnostic and therapeutic application, in national cancer plans; and
- improve evidence for clinical efficacy of novel cancer interventions involving ionising radiation.
Funding Information
- The available budget for this call is EUR 3 500 000.
Eligibility Criteria
In order to be eligible for funding, the applicants (beneficiaries and affiliated entities) must:
- be legal entities (public or private bodies) created under Union law or an international organisation, or
- be established in one of the eligible countries, i.e.:
- EU Member States (including overseas countries and territories linked to it (OCTs)
- eligible non-EU countries:
- EEA countries and countries associated to the EU4Health Programme (third countries, candidate countries and potential candidate countries, neighbourhood countries) or countries which are in ongoing negotiations for an association agreement and where the agreement enters into force before grant signature.
For more information, visit https://bit.ly/2X2LYF6